30.Kolterman O, Gottlieb A, Gaines E, Fineman M 2000 Five-day dosing of synthetic exendin-4 (AC2993) in people with type 2 diabetes reduces post-prandial glucose, glucagon and triglyceride concentrations. Diabetologia 43:A189 (Abstract) 31.Kim D, Taylor K, Bicsak T, Wang Y, Aisporna M, Heintz S, Fineman MS, Baron A 2002 Subcutaneous injection of AC2993 (synthetic exendin-4) lowered fasting glucose concentrations through suppression of glucagon and dosedependent insulinotropism in patients with type 2 diabetes. Diabetes 51:A104(Abstract) 32.Clements JA, Heading RC, Nimmo WS, Prescott LF 1978 Kinetics of acet- aminophen absorption and gastric emptying in man. Clin Pharmacol Ther24:420 –431 33.Peterson JI, Young DS 1968 Evaluation of the hexokinase-glucose-6-phos-phate dehydrogenase method of determination of glucose in urine. Anal Bio- chem 1968 23:301 –316 34.Schmidt FH 1973 Blood glucose levels in capillary blood of adults assessed by the hexokinase method. Klin Wochenschr 51:520 –522